Pharmacopuncture Therapy for Cervical Disc Herniation: A Pilot Study
Pragmatic Randomized Controlled Trial of Pharmacopuncture Therapy for Cervical Disc Herniation: A Pilot Study
1 other identifier
interventional
84
1 country
7
Brief Summary
This is pilot study for a 3-arm parallel pragmatic randomized controlled trial that will compare pharmacopuncture therapy, acupunture therapy and physical therapy, medication(prn) for cervical disc herniation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2022
7 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 13, 2022
CompletedFirst Posted
Study publicly available on registry
February 15, 2022
CompletedStudy Start
First participant enrolled
April 20, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 26, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 26, 2023
CompletedMarch 14, 2025
March 1, 2025
1.1 years
February 13, 2022
March 12, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Numeric rating scale (NRS) of neck pain
NRS is a pain scale in which the patient indicates their subjective pain as a whole number from 0 to 10, where 0 indicates 'no pain or discomfort' and 10 indicates 'the most severe pain and discomfort imaginable'.
Week 1, 2, 3, 4, 5, 6, 7, 13, 25
Secondary Outcomes (7)
Numeric rating scale (NRS) of radiating arm pain
Week 1, 2, 3, 4, 5, 6, 7, 13, 25
Visual analogue scale (VAS) of neck pain and radiating arm pain
Week 1, 2, 3, 4, 5, 6, 7, 13, 25
Neck Disability Index (NDI)
Week 1, 7, 13, 25
Northwick Park Questionnaire (NPQ)
Week 1, 7, 13, 25
Patient Global Impression of Change (PGIC)
Week 7, 13, 25
- +2 more secondary outcomes
Study Arms (3)
pharmacopunture therapy
EXPERIMENTALThe physicians will choose the type and volume of pharmacopuncture according to participants' conditions.
acupuncture therapy
ACTIVE COMPARATORThe physicians will choose the type and number of acupuncture therapy according to participants' conditions.
physical therapy, medication(prn)
ACTIVE COMPARATORThe physicians will choose the type and time of physical therapy according to participants' conditions. According to clinical judgment, clinicians can prescribe analgesics and muscle relaxants if necessary.
Interventions
This is a pragmatic RCT, so the physicians will choose the type and volume of pharmacopuncture according to participants' conditions.
This is a pragmatic RCT, so the physicians will choose the type and number of acupuncture therapy according to participants' conditions.
This is a pragmatic RCT, so the physicians will choose the type and time of physical therapy according to participants' conditions. According to clinical judgment, clinicians can prescribe analgesics and muscle relaxants if necessary.
Eligibility Criteria
You may qualify if:
- Symptoms of cervical disc herniation for less than 12 months
- Numeric Rating Scale (NRS) of neck pain is more than 5
- Symptoms of neuromuscular disease in one or both upper limbs (pain, pull, numbness, sensory abnormalities, motor abnormalities)
- Discrimination findings above protusion, which can explain clinical symptoms on Cervical spine MRI or CT
- years old
- participants who agreed and wrote informed consents
You may not qualify if:
- Case of being diagnosed with a specific serious disease that may cause neck pain(Migration of cancer reaching to spine, acute fracture of spine, spine dislocation)
- Progressive neurologic deficits or severe neurologic deficits
- Cause of pain due to soft tissue disease, not the spine(Cancer, fibromyalgia, RA, goat, or etc.)
- Other chronic diseases(stroke, MI, kidney disease, diabetic neuropathy, dimentia, epilepsy, or etc.) that may interfere with the interpretation of therapeutic effects or outcomes
- Participants taking steroid, immunosuppressant, psychotropic medication, or taking other drugs that may affect outcomes
- Inappropriate or unsafe pharmacopuncture therapy; hemorrhagic disease, taking anticoagulant drug, or severe diabetes patients who are likely to be infected
- Participants who took NSAIDs or pharmacopuncture, acupuncture, physical therapy within 1 week
- Pregnant, planning to get pregnant or lactating women
- Participants who had undergone cervical surgery within 3 months
- Participants who had participated in other clinical trial within 1 month, had participated in other study within 6 months from the date of selection, or have plan for participation in other trial during follow up period of this trial
- Participants who can not write informed consent
- Participants who is difficult to participate in the trial according to investigator's decision
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (7)
Kyung Hee University Korean Medicine Hospital
Seoul, Dongdaemun-gu, 130-701, South Korea
Kyung Hee University Korean Medicine Hospital at Gangdong
Seoul, Gangdong-gu, 05278, South Korea
Jaseng Hospital of Korean Medicine
Seoul, Gangnam-Gu, 135-896, South Korea
Bucheon Jaseng Hospital of Korean Medicine
Bucheon-si, Gyeonggi Province, 14598, South Korea
Dongguk University Bundang Oriental Hospital
Seongnam-si, Gyeonggi-do, 13601, South Korea
Haeundae Jaseng Hospital of Korean Medicine
Busan, South Korea
Daejeon Jaseng Hospital of Korean Medicine
Daejeon, 35262, South Korea
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
In-Hyuk Ha, Ph.D.
Jaseng Medical Foundation
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director
Study Record Dates
First Submitted
February 13, 2022
First Posted
February 15, 2022
Study Start
April 20, 2022
Primary Completion
May 26, 2023
Study Completion
September 26, 2023
Last Updated
March 14, 2025
Record last verified: 2025-03